Abstract Details

Title TITRE: Dedicated Mobile Application for Drug Adverse Reactions Reporting by Patients with Relapsing Remitting Multiple Sclerosis: a Multicenter Cluster-Randomized Controlled Trial

Topic Multiple Sclerosis

Presentation(s) P4 - (-)

Poster/Presentation
Number 396

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Gilles Defer, MD (Hopital Cote De Nacre) PRESENTER	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��